| 1 | Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis | Frontiers in Oncology | C. Chouaïd, D. Debieuvre et al. | 1 |
| 2 | Treatment-Free Survival Over 6 Years of Follow-up in Patients With Metastatic NSCLC Treated With First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 227 Part 1 | Journal of Thoracic Oncology | Solange Peters, Meredith M. Regan et al. | 0 |
| 3 | Population-Adjusted Indirect Treatment Comparisons of Repotrectinib Among Patients with ROS1+ NSCLC | Cancers | Jürgen Wolf, Sarah Goring et al. | 0 |
| 4 | Treatment-Switching Adjustment of Overall Survival in CheckMate 227 Part 1 Evaluating First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy for Metastatic Nonsmall Cell Lung Cancer | Clinical Lung Cancer | Martin Reck, Luis Paz‐Ares et al. | 0 |
| 5 | Cost-Effectiveness of Nivolumab Plus Ipilimumab versus Chemotherapy for Previously Untreated Metastatic NSCLC Using Mixture-Cure Survival Analysis Based on CheckMate 227 5-Year Data | PharmacoEconomics - Open | Alison Griffiths, Yong Yuan et al. | 0 |
| 6 | Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: a real-world evidence survey | BMC Cancer | Adam Lee, Laura J. Eccles et al. | 7 |
| 7 | Galacto-oligosaccharides fed during gestation increase Rotavirus A specific antibodies in sow colostrum, modulate the microbiome, and reduce infectivity in neonatal piglets in a commercial farm setting | Frontiers in Veterinary Science | Adam Lee, Lu Liang et al. | 5 |
| 8 | COVID-19 data driven planning: The SouthEast Texas approach | Journal of Emergency Management | Adam Lee et al. | 0 |
| 9 | Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States—October 25, 2020–February 26, 2022 | The Lancet Regional Health - Americas | Ryan E. Wiegand, Yangyang Deng et al. | 29 |
| 10 | Cost-effectiveness analysis of nivolumab plus ipilimumab versus platinum-doublet chemotherapy for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United States | Journal of Medical Economics | Mohammad A. Chaudhary, Yong Yuan et al. | 5 |
| 11 | Treatment patterns for advanced non-small cell lung cancer in the US: A systematic review of observational studies | Cancer Treatment and Research Communications | Adam Lee, Yong Yuan et al. | 5 |
| 12 | Correlations between objective response rate and survival-based endpoints in first-line advanced non-small cell lung Cancer: A systematic review and meta-analysis | Lung Cancer | Sarah Goring, N. Varol et al. | 7 |
| 13 | Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer Centre | BMC Cancer | Chris Twelves, Sue Cheeseman et al. | 11 |
| 14 | Changes to the sample design and weighting methods of a public health surveillance system to also include persons not receiving HIV medical care | PLoS ONE | Christopher H. Johnson, Linda Beer et al. | 4 |
| 15 | Cost-effectiveness Analysis of Ribociclib plus Letrozole versus Palbociclib plus Letrozole in the United Kingdom | Journal of health economics and outcomes research | Gaurav Suri, David Chandiwana et al. | 1 |
| 16 | Cost-effectiveness Analysis of Ribociclib plus Letrozole versus Palbociclib plus Letrozole in the United Kingdom | Journal of health economics and outcomes research | Gaurav Suri, David Chandiwana et al. | 12 |
| 17 | Juvenile Polyposis coli in a 9 year old boy | | Adam Lee, Judy Ho et al. | 1 |
| 18 | Common Genetic Variation in CYP17A1 and Response to Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer | International Journal of Molecular Sciences | Moritz Binder, Ben Zhang et al. | 19 |
| 19 | Genotypic characterization of dihydropyrimidinase andβ-ureidopropionase in an African American and Caucasian population: New potential pharmacogenetic markers for 5-fluorouracil toxicity in the African American population | Cancer Epidemiology and Prevention Biomarkers | Hany Ezzeldin, Lori K. Mattison et al. | 1 |
| 20 | Isodicentric Philadelphia chromosomes in imatinib mesylate (Gleevec)-resistant patients | Cancer Genetics and Cytogenetics | Jane L. Liesveld, M. Anwar Iqbal et al. | 7 |